SMTI MDXG Mimedx to acquire Sanara Medtech Sanara Medtech - Mimedx to buy Sanara in deal valued at $35 per share, enterprise value $350M San
SMTI MDXG Mimedx to acquire Sanara Medtech Sanara Medtech - Mimedx to buy Sanara in deal valued at $35 per share, enterprise value $350M Sanara Medtech - Mimedx to finance deal with cash on hand and $300M term loan from hayfin - Combined 2027 revenue expected to exceed $400M, adj EBITDA margin over 20% - Anticipates over $20M in run-rate cost synergies Sanara Medtech Inc: deal immediately accretive to revenue growth, gross margin and adjusted EBITDA margin
SMTI MDXG Mimedx to acquire Sanara Medtech Sanara Medtech - Mimedx to buy Sanara in deal valued at $35 per share, enterprise value $350M Sanara Medtech - Mimedx to finance deal with cash on hand and $300M term loan from hayfin - Combined 2027 revenue expected to exceed $400M, adj EBITDA margin over 20% - Anticipates over $20M in run-rate cost synergies Sanara Medtech Inc: deal immediately accretive to revenue growth, gross margin and adjusted EBITDA margin